WO1998004249A3 - Tramadol multiple unit formulierungen - Google Patents

Tramadol multiple unit formulierungen Download PDF

Info

Publication number
WO1998004249A3
WO1998004249A3 PCT/EP1997/003934 EP9703934W WO9804249A3 WO 1998004249 A3 WO1998004249 A3 WO 1998004249A3 EP 9703934 W EP9703934 W EP 9703934W WO 9804249 A3 WO9804249 A3 WO 9804249A3
Authority
WO
WIPO (PCT)
Prior art keywords
multiple unit
unit formulations
tramadol
tramadol multiple
enveloped
Prior art date
Application number
PCT/EP1997/003934
Other languages
English (en)
French (fr)
Other versions
WO1998004249A2 (de
Inventor
Helmut Momberger
Marc Raber
Dieter Kuhn
Wolfgang Schmid
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL12791597A priority Critical patent/IL127915A/en
Priority to JP50846698A priority patent/JP3631762B2/ja
Priority to EP97935532A priority patent/EP0917463B1/de
Priority to HU9903053A priority patent/HU227971B1/hu
Priority to DK97935532T priority patent/DK0917463T3/da
Priority to AT97935532T priority patent/ATE213408T1/de
Priority to PL97331387A priority patent/PL188834B1/pl
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Priority to UA99021086A priority patent/UA52679C2/uk
Priority to BR9710761A priority patent/BR9710761A/pt
Priority to AU38491/97A priority patent/AU737121B2/en
Priority to DE59706441T priority patent/DE59706441D1/de
Priority to EEP199900031A priority patent/EE03742B1/xx
Priority to SK98-99A priority patent/SK285300B6/sk
Priority to NZ333822A priority patent/NZ333822A/xx
Publication of WO1998004249A2 publication Critical patent/WO1998004249A2/de
Publication of WO1998004249A3 publication Critical patent/WO1998004249A3/de
Priority to NO19990261A priority patent/NO324207B1/no
Priority to BG103158A priority patent/BG63708B1/bg
Priority to HK99106029A priority patent/HK1020876A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Es werden pharmazeutische Multiple Unit Formulierungen beschrieben, welche einzelne gleich oder unterschiedlich retardierte Pellets enthalten, bestehend aus einem mit Tramadol oder dessen physiologisch verträglichen Salzen überzogenen Startermaterial, welches mit einer oder mehreren Membranschichten aus mindestens einem pharmazeutisch akzeptablen, die Freisetzung verzögernden Stoff überzogen ist. Die Multiple Unit Formulierungen können in Form von Kapseln oder Tabletten verabreicht werden.
PCT/EP1997/003934 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen WO1998004249A2 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SK98-99A SK285300B6 (sk) 1996-07-25 1997-07-19 Farmaceutická formulácia obsahujúca množinu liekových podjednotiek a spôsob jej výroby
EP97935532A EP0917463B1 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen
HU9903053A HU227971B1 (en) 1996-07-25 1997-07-19 Tramadol multiple unit formulations and process for producing them
DK97935532T DK0917463T3 (da) 1996-07-25 1997-07-19 Tramadol-flerenhedsformuleringer
AT97935532T ATE213408T1 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen
PL97331387A PL188834B1 (pl) 1996-07-25 1997-07-19 Farmaceutyczne formulacje zawierające tramadol lub jego fizjologicznie akceptowane sole oraz sposóbwytwarzania tych formulacji
AU38491/97A AU737121B2 (en) 1996-07-25 1997-07-19 Tramadol multiple unit formulations
UA99021086A UA52679C2 (uk) 1996-07-25 1997-07-19 Фармацевтична композиція, що містить велику кількість одиниць трамадолу, і спосіб її приготування
BR9710761A BR9710761A (pt) 1996-07-25 1997-07-19 Formula-{es de unidade mÚltipla de tramadol
IL12791597A IL127915A (en) 1996-07-25 1997-07-19 Preparations with many units of tramadol consisting of sustained release pills
DE59706441T DE59706441D1 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen
EEP199900031A EE03742B1 (et) 1996-07-25 1997-07-19 Tramadooli mitmikühikulised preparaadid ja nende valmistamismeetod
JP50846698A JP3631762B2 (ja) 1996-07-25 1997-07-19 トラマドール複式ユニット製剤
NZ333822A NZ333822A (en) 1996-07-25 1997-07-19 Tramadol multiple unit formulations comprising individual pellets of trmadol coated with one or more membrane layers for controlling release
NO19990261A NO324207B1 (no) 1996-07-25 1999-01-21 Farmasoytiske multiple enhetsformuleringer med tramadol, samt fremgangsmate til fremstilling derav.
BG103158A BG63708B1 (bg) 1996-07-25 1999-02-09 Лекарствени форми на трамадол
HK99106029A HK1020876A1 (en) 1996-07-25 1999-12-22 Tramadol multiple unit formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630035A DE19630035A1 (de) 1996-07-25 1996-07-25 Tramadol Multiple Unit Formulierungen
DE19630035.5 1996-07-25

Publications (2)

Publication Number Publication Date
WO1998004249A2 WO1998004249A2 (de) 1998-02-05
WO1998004249A3 true WO1998004249A3 (de) 1998-04-30

Family

ID=7800815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/003934 WO1998004249A2 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen

Country Status (29)

Country Link
US (2) US5955104A (de)
EP (1) EP0917463B1 (de)
JP (1) JP3631762B2 (de)
KR (1) KR100474793B1 (de)
CN (1) CN1111402C (de)
AR (1) AR008002A1 (de)
AT (1) ATE213408T1 (de)
AU (1) AU737121B2 (de)
BG (1) BG63708B1 (de)
BR (1) BR9710761A (de)
CA (1) CA2211284C (de)
CZ (1) CZ296964B6 (de)
DE (2) DE19630035A1 (de)
DK (1) DK0917463T3 (de)
EE (1) EE03742B1 (de)
ES (1) ES2171268T3 (de)
HK (1) HK1020876A1 (de)
HU (1) HU227971B1 (de)
IL (1) IL127915A (de)
NO (1) NO324207B1 (de)
NZ (1) NZ333822A (de)
PL (1) PL188834B1 (de)
PT (1) PT917463E (de)
RU (1) RU2201223C2 (de)
SK (1) SK285300B6 (de)
TW (1) TW495363B (de)
UA (1) UA52679C2 (de)
WO (1) WO1998004249A2 (de)
ZA (1) ZA975408B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
DE19901686A1 (de) * 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
HUP0203623A2 (hu) * 1999-08-31 2003-02-28 Grünenthal GmbH Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (de) 1999-10-29 2011-03-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
US20030157247A1 (en) * 2000-06-14 2003-08-21 Yoshiro Chikami Method for producing coated bioactive granule
US20020077364A1 (en) * 2000-07-06 2002-06-20 Ramaswamy Murari Thyroid hormone formulations
KR101167465B1 (ko) 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
AU2002355266A1 (en) * 2001-07-23 2003-02-17 Brigham And Women's Hospital, Inc. Analgesic methods using endothelin receptor ligands
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
AU2003211146B2 (en) * 2002-02-21 2007-07-19 Valeant International (Barbados) Srl Controlled release dosage forms
US8128957B1 (en) * 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
EP1542658B1 (de) * 2002-08-15 2010-12-29 Euro-Celtique S.A. Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
ES2269591T3 (es) * 2002-11-27 2007-04-01 ORAMON-ARZNEIMITTEL GMBH & CO. KG Procedimiento para la fabricacion de granulados que contienen un antidepresivo triciclico o tetraciclico, asi como preparaciones farmaceuticas que contienen estos granulados.
US20060153915A1 (en) * 2003-01-23 2006-07-13 Amorepacific Corporation Sustained-release preparations and method for producing the same
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
US20050074493A1 (en) * 2003-10-03 2005-04-07 Mehta Atul M. Extended release formulations of opioids and method of use thereof
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
EP1771159A4 (de) * 2004-07-22 2009-04-29 Amorepacific Corp Zubereitungen mit verzögerter freisetzung mit topiramat und herstellungsverfahren dafür
EP1786404A2 (de) 2004-09-01 2007-05-23 Euro-Celtique S.A. Opioid-dosierformen mit steady-state-cave proportional zur dosierung und auc und einzeldosen-cmax geringer als proportional zur dosierung
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
WO2006070930A1 (en) 2004-12-27 2006-07-06 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2007016948A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung
US20070104788A1 (en) * 2005-11-10 2007-05-10 Seamus Mulligan Once-daily administration of central nervous system drugs
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
ATE476176T1 (de) * 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
CA2923102C (en) * 2007-08-13 2019-10-15 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
CN101095666B (zh) * 2007-08-14 2010-10-06 石药集团欧意药业有限公司 一种盐酸曲马多缓释片剂及其制备方法
CZ300468B6 (cs) * 2007-09-20 2009-05-27 Zentiva, A. S Léková forma obsahující tramadol s kontrolovaným uvolnováním po dobu 24 hodin a zpusob její prípravy
US20100285119A1 (en) * 2008-01-11 2010-11-11 Jubilant Organosys Ltd. Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
EP2331076B1 (de) * 2008-09-04 2015-03-04 Farnam Companies, Inc. Formulierungen zum kauen mit verzögerter freisetzung
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
PT2358360T (pt) 2008-11-18 2016-11-15 Ucb Biopharma Sprl Formulações de libertação prolongada compreendendo um derivado de 2-oxo-1-pirrolidina
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
WO2012003968A1 (en) 2010-07-06 2012-01-12 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
CA2877774C (en) 2012-07-12 2017-07-18 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
WO2014146093A2 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093200A (en) * 1985-10-23 1992-03-03 Eisai Co., Ltd. Multilayer sustained release granule
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
WO1995014460A1 (en) * 1993-11-23 1995-06-01 Euro-Celtique S.A. Opioid formulations for treating pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093200A (en) * 1985-10-23 1992-03-03 Eisai Co., Ltd. Multilayer sustained release granule
WO1995014460A1 (en) * 1993-11-23 1995-06-01 Euro-Celtique S.A. Opioid formulations for treating pain
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5474786A (en) * 1994-03-23 1995-12-12 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form

Also Published As

Publication number Publication date
US6436438B1 (en) 2002-08-20
PL188834B1 (pl) 2005-04-29
UA52679C2 (uk) 2003-01-15
NO324207B1 (no) 2007-09-10
AU737121B2 (en) 2001-08-09
CN1111402C (zh) 2003-06-18
DK0917463T3 (da) 2002-06-10
ES2171268T3 (es) 2002-09-01
RU2201223C2 (ru) 2003-03-27
PT917463E (pt) 2002-07-31
HU227971B1 (en) 2012-07-30
HUP9903053A3 (en) 2000-02-28
NZ333822A (en) 1999-11-29
DE19630035A1 (de) 1998-01-29
JP2000515871A (ja) 2000-11-28
EE9900031A (et) 1999-08-16
AR008002A1 (es) 1999-11-24
DE59706441D1 (de) 2002-03-28
US5955104A (en) 1999-09-21
BG103158A (en) 1999-08-31
IL127915A0 (en) 1999-11-30
EP0917463A2 (de) 1999-05-26
HUP9903053A2 (hu) 2000-01-28
BR9710761A (pt) 1999-08-17
WO1998004249A2 (de) 1998-02-05
BG63708B1 (bg) 2002-10-31
IL127915A (en) 2001-08-08
ATE213408T1 (de) 2002-03-15
ZA975408B (en) 1998-01-05
EE03742B1 (et) 2002-06-17
CA2211284C (en) 2001-10-23
HK1020876A1 (en) 2000-05-26
CZ18599A3 (cs) 1999-04-14
AU3849197A (en) 1998-02-20
SK285300B6 (sk) 2006-10-05
CA2211284A1 (en) 1998-01-25
KR100474793B1 (ko) 2005-03-08
KR20000029530A (ko) 2000-05-25
CZ296964B6 (cs) 2006-08-16
PL331387A1 (en) 1999-07-05
CN1226824A (zh) 1999-08-25
JP3631762B2 (ja) 2005-03-23
SK9899A3 (en) 1999-09-10
EP0917463B1 (de) 2002-02-20
NO990261D0 (no) 1999-01-21
NO990261L (no) 1999-01-21
TW495363B (en) 2002-07-21

Similar Documents

Publication Publication Date Title
WO1998004249A3 (de) Tramadol multiple unit formulierungen
UY23804A1 (es) Procedimiento de preparacion de medicamentos en forma de comprimidos con liberacion retardada de sustancia activa.
EP2103303A3 (de) Tramadolhaltige Formulierung mit gesteuerter Freisetzung
IL120382A (en) Extended release formulation of venlafaxine hydrochloride
CA2232450A1 (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
JO2555B1 (en) Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
CA2240329A1 (en) Improved delivery of multiple doses of medications
AU8009998A (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
CA2348090A1 (en) Oral pulsed dose drug delivery system
AU4464897A (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
AU5335698A (en) Pharmaceutical formulations with delayed drug release
ATE213629T1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
EP1287822A3 (de) Mesalazine enthaltende pharmazeutische Zusammensetzungen mit gesteuerter Freisetzung
EP1435240A3 (de) Feste orale Dosierungsformen enthaltend eine Kombination von Glibenclamid und Metformin
AU1351788A (en) Slow-release pharmaceutical agent
WO1999022724A3 (en) Extended release formulation containing venlafaxin
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
HUP0004966A3 (en) Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
HUP0002719A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
DK1171111T3 (da) Granulat, som har højt indhold af L-carnitin eller et alkanoyl L-carnitin, og som er særlig egnet til fremstilling af tabletter ved direkte presning

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97196651.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BG BR BY CA CN CZ EE HU IL JP KR LT LV MX NO NZ PL RU SG SK UA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BG BR BY CA CN CZ EE HU IL JP KR LT LV MX NO NZ PL RU SG SK UA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997935532

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PV1999-185

Country of ref document: CZ

Ref document number: 333822

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 9899

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/000903

Country of ref document: MX

Ref document number: 1019997000586

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV1999-185

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1997935532

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1019997000586

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1997935532

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1019997000586

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: PV1999-185

Country of ref document: CZ